This Project At LMU Looks At How Using AI 2nd Opinion Report to Analyze Retinal Eye Scans Impact Doctors' Decisions About Treatment for Patients with a Specific Eye Disease (nAMD)

NANot yet recruitingINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

January 30, 2025

Primary Completion Date

January 30, 2026

Study Completion Date

January 30, 2026

Conditions
Neovascular Age-Related Macular Degeneration (nAMD)
Interventions
BEHAVIORAL

AI assisted assessment of SD-OCT scans

AI 2nd opinion report on nAMD treatment planning

Trial Locations (1)

80336

LMU Klinikum, Munich

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Deepeye Medical GmbH

INDUSTRY

collaborator

Technomics Research

INDUSTRY

collaborator

M3 Macula Monitor Muenster

UNKNOWN

lead

Johannes Schiefelbein

OTHER